News from the healthcare data industry
CAMBRIDGE, Mass., Aug. 2, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS company, announced today the integration of MiradaXD, the multi-modality nuclear medicine imaging software by Mirada Medical,...
CAMBRIDGE, Mass., July 27, 2023 /PRNewswire/ — Advanced visualization and AI leader TeraRecon, a ConcertAI company, announced today a strategic partnership with ClariPi, an innovative medical imaging AI company, to integrate ClariPi’s...
IRVING, Texas and CAMBRIDGE, Mass., June 1, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, and ConcertAI,...
ConcertAI’s TeraRecon Inc. recognized as an ISO 27001:2022 certified company. CAMBRIDGE, Mass., May 30, 2023 /PRNewswire/ — TeraRecon, the advanced visualization and clinical AI SaaS category leader, today announced that it has...
CAMBRIDGE, Mass., May 26, 2023 /PRNewswire/ — The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, now provides clinicians with the state-of-the-art clinical artificial intelligence and deep...
State-of-the-art structural heart capabilities simplify pre-op planning for interventional clinicians through automated workflows and enhanced interoperability CAMBRIDGE, Mass., May 11, 2023 – ConcertAI’s TeraRecon, the advanced visualization (AV) and clinical...
The industry’s only global and open clinical AI SaaS Platform with the goal of optimizing clinical workflow, reducing physician burnout, and improving clinical outcomes CAMBRIDGE, Mass., May 8, 2023 /PRNewswire/ — ConcertAI’s...
The industry’s only global and open clinical AI SaaS Platform with the goal of optimizing clinical workflow, reducing physician burnout, and improving clinical outcomes CAMBRIDGE, Mass., May 8, 2023 /PRNewswire/ — ConcertAI’s...
CAMBRIDGE, Mass., April 28, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, has announced the release of its AI-driven clinical suite, Neuro Suite. Purpose-built for disease...
CAMBRIDGE, Mass., April 27, 2023 /PRNewswire/ — The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to bring comprehensive neuroradiology solutions to...